Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes)

Comparative Medicine

Volumn 59, Issue 3, 2009, Pages 287-296

  Videan, Elaine N ^a   Heward, Christopher B ^b   Chowdhury, Kajal ^b,c   Plummer, John ^b   Su, Yali ^b   Cutler, Richard G ^b  

^a Alamogordo Primate Facility   (United States)

^b Kronos Science Laboratories   (United States)

^c FOLEY AND LARDNER LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYL 2 DEOXYURIDINE; 8 ISOPROSTAGLANDIN F 2 ALPHA; ALBUMIN; ALPHA CAROTENE; ANTIOXIDANT; BETA CAROTENE; BETA CRYPTOXANTHIN; BILIRUBIN; BIOLOGICAL MARKER; CERULOPLASMIN; COPPER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN A; LYCOPENE; SOMATOMEDIN C; TOCOPHEROL; UNCLASSIFIED DRUG;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHIMPANZEE; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PAN TROGLODYTES; SPECIES COMPARISON; ANIMAL; BLOOD; COMPARATIVE STUDY; LIFE EXPECTANCY; LIPID PEROXIDATION; LONGEVITY; PHYSIOLOGY; REFERENCE VALUE; RISK FACTOR; SPECIES DIFFERENCE;

ADULT; AGING; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; LIFE EXPECTANCY; LIPID PEROXIDATION; LONGEVITY; MALE; OXIDATIVE STRESS; PAN TROGLODYTES; REFERENCE VALUES; RISK FACTORS; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 68349086883     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Anemone RL, Watts ES, Swindler DR. 1991. Dental development of known-age chimpanzees, Pan troglodytes. Am J Phys Anthropol 86:229-241.
2. Arosio M, Sartore G, Rossi CM, Casati G, Faglia G, Manzato E, Italian multicenter octreotide study group. 2000. LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octeotide therapy. Atherosclerosis 151:551-557.
3. Austad SN, Fischer KE. 1992. Primate longevity: its place in the mammalian scheme. Am J Primatol 28:251-261.
4. Barja G. 2002. Rate of generation of oxidative stress-related damage and animal longevity. Free Radic Biol Med 33:1167-1172.
5. Becker BF. 1993. Towards the physiological-function of uric acid. Free Radic Biol Med 14:615-631.
6. Beckman KB, Ames BN. 1998. The free radical theory of aging matures. Physiol Rev 78:547-581.
7. Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP. 2000. Low plasma lecithin: cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. Atherosclerosis 153:491-498.
8. Boero L, Manavelat M, Rosso LG, Insua C, Berardi V, Fornari MC, Brites F. 2009. Alterations in biomarkers of cardiovascular disease (CVD) in active acromegaly. Clin Endocrinol (Oxf) 70:88-95.
9. Bowden DM, Short R, Williams D. 1990. Constructing an instrument to measure the rate of aging in female pigtailed macaques (Macaca nemestrina). J Gerontol 45:B59-B66.
10. Chu NF, Wang DJ, Liou SH, Shief SM. 2000. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 16:13-17.
11. Clarke R, Armitage J. 2002. Antioxidant vitamins and risk of cardiovascular disease: review of large-scale randomized trials. Cardiovasc Drugs Ther 16:411-415.
12. Clyde VL, Roth L, Bell B, Wallace R, Slosky D, Dolan J. 2002. Cardiac and gestational ultrasound parameters in nonanesthetized bonobos (Pan paniscus). Proc Am Assoc Zoo Vet Annu Meet. 2002:365-368.
13. Colao A, Marzullo P, Di Somma C, Lombardi G. 2001. Growth hormone and the heart. Clin Endocrinol (Oxf) 54:137-154.
14. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, Di Somma C, Assanti AP, Lombardi G. 2001. Increased arterial intima-media thickness by B-M mode echodopplar ultrasonography in acromegaly. Clin Endocrinol (Oxf) 54:515-524.
15. Crissey SD, Barr JE, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M, Langman C, Ward A, Ange K. 1999. Serum concentrations of lipids, vitamins A and E, vitamin D metabolites, and carotenoids in nine primate species at four zoos. Zoo Biol 18:551-564.
16. Cutler RG. 1976. Evolution of longevity in primates. J Hum Evol 5:169-202.
17. Cutler RG. 1984. Carotenoids and retinol: their possible importance in determining longevity of primate species. Proc Natl Acad Sci USA 81:7627-7631.
18. Cutler RG. 1984. Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3:321-348.
19. Cutler RG. 1985. Peroxide-producing potential of tissues: inverse correlation with longevity in mammalian species. Proc Natl Acad Sci USA 82:4798-4802.
20. Cutler RG. 1986. Aging and oxygen radicals, p 251-285. In: Taylor AE, Matalon S, Ward P, editors. Physiology of oxygen radicals. Bethesda (MD): American Physiological Society.
21. Cutler RG. 1991. Antioxidants and aging. Am J Clin Nutr 53:373S-379S.
22. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. 2006. Biomarkers of oxidative damage in human disease. Clin Chem 52:601-623.
23. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. 2001. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196-1200.
24. Duan X, Ling F. 2008. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578-581.
25. Dudman NPB. 1999. An alternative view of homocysteine. Lancet 354:2072-2074.
26. Ensign W, Hill N, Heward CB. 2006. Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. Clin Chem 52:1722-1727.
27. Fang ZY, Prins JB, Marwick TH. 2004. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543-567.
28. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247.
29. Ford ES. 2000. Serum copper concentrations and coronary heart disease among US adults. Am J Epidemiol 151:1182-1188.
30. Freedman DS, Williamson DF, Gunter EW, Byers T. 1995. Relation to serum uric-acid to mortality and ischemic-heart disease - the Nhanes I epidemiologic follow-up study. Am J Epidemiol 141:637-644.
31. Garcia AL, Raila J, Koebnick C, Eulenberger K, Schweigert FJ. 2006. Great apes show highly selective plasma carotenoids and have physiologically high plasma retinyl esters compared to humans. Am J Phys Anthropol 131:236-242.
32. Gavan JA. 1953. Growth and development of the chimpanzee: a longitudinal and comparative study. Hum Biol 25:93-143.
33. Gillum RF, Makuc DM. 1992. Serum albumin, coronary heart disease, and death. Am Heart J 123:507-513.
34. Giurgea N, Constantinescu MI, Stanciu R, Suclu S, Muresan A. 2005. Ceruloplasmin: acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit 11:RA48-RA51.
35. Glader CA, Birgander LS, Stetlund H, Dalén GH. 2002. Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden. J Intern Med 252:27-35.
36. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. 2005. Uric acid and oxidative stress. Curr Pharm Des 11:4145-4151.
37. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, Stampfer MR. 2004. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 35:1584-1588.
38. Halliwell B. 1988. Albumin - an important extracellular antioxidant. Biochem Pharmacol 37:569-571.
39. Hamada Y, Chatani K, Udono T, Kikuchi Y, Gunjii H. 2003. A longitudinal study on hand and wrist skeletal maturation in chimpanzees (Pan troglodytes), with emphasis on growth in linear dimensions. Primates 44:259-271.
40. Hansen JF, Alford PL, Keeling ME. 1984. Diffuse myocardial fibrosis and congestive heart failure in an adult male chimpanzee. Vet Pathol 21:529-531.
41. Harman D. 1956. Aging: a theory based on free radical and radiation chemistry. J Gerontol 2:298-300.
42. 2α measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 35:1301-1309.
43. Harrela M, Qiao Q, Koistinen R, Tuomilehto J, Nissinen A, Seppala M, Leinonen P. 2002. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 34:144-149.
44. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, Cobain MR, Powell J, Blauw GJ, van der Ouderaa F, Westendorp RGJ, Slagboom PE. 2006. Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 3:e495.
45. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-1149.
46. Herndon JG, Tigges J. 2001. Hematolgic and blood biochemical variables of captive chimpanzees: cross-sectional and longitudinal analyses. Comp Med 51:60-69.
47. Hill K, Boesch C, Goodall J, Pusey A, Williams J, Wrangham R. 2001. Mortality rates among wild chimpanzees. J Hum Evol 40:437-450.
48. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, Harrison DG, Fukai T. 2002. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 22:1402-1408.
49. Hu JJ, Chi CX, Frenkel K, Smith BM, Henfelt JJ, Berwick M, Mahabir S, D'Agostino RB. 1999. Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2'-deoxyurdine (HMdU). Cancer Epidemiol Biomarkers Prev 8:693-698.
50. Hubbard GB, Lee DR, Eichberg JW. 1991. Diseases and pathology of chimpanzees at the Southwest Foundation for Biomedical Research. Am J Primatol 24:273-282.
51. Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
52. Ito Y, Kurata M, Suzuki K, Hamajima N, Hishida H, Aoki K. 2006. Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study. J Epidemiol 16:154-160.
53. Kaliora AC, Dedoussis GVZ, Schmidt H. 2006. Dietary antioxidants in preventing atherogensis. Atherosclerosis 187:1-17.
54. Kaul S, Zadeh AA, Shah PK. 2006. Homocysteine hypothesis for atherothrombotic cardiovascular disease - not validated. J Am Coll Cardiol 48:914-923.
55. Kono Y, Nakamura K, Kimura H, Nishii N, Watanabe A, Banba K, Miura A, Nagase S, Sakuragi S, Kusano KF, Matsubara H, Ohe T. 2006. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 70:1001-1005.
56. Krauss RM. 1987. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J 113:578-582.
57. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. 2000. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 152:1065-1071.
58. Ku H-H, Brunk UT, Sohal RS. 1993. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic Biol Med 15:621-627.
59. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP. 1991. The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol 134:1266-1277.
60. Kuykendall KL, Conroy GC. 1996. Permanent tooth calcification in chimpanzees (Pan troglodytes): patterns and polymorphisms. Am J Phys Anthropol 99:159-174.
61. Lammey ML, Baskin GB, Gigliotti AP, Lee DR, Ely JJ, Sleeper MM. 2008. Interstitial myocardial fibrosis in a captive chimpanzee (Pan troglodytes) population. Comp Med 58:389-394.
62. Lammey ML, Lee DR, Ely JJ, Sleeper MM. 2008. Sudden cardiac death in 13 captive chimpanzees (Pan troglodytes). J Med Primatol 37 Suppl 1:39-43.
63. Lane MA. 2000. Nonhuman primate models in biogerontology. Exp Gerontol 35:533-541.
64. Lee DR, Guhad PA. 2001. Chimpanzee health care and medicine program, p 63-117. In: Brent L, editor. Special topics in primatology: the care and management of captive chimpanzees. San Antonio (TX): American Society of Primatologists.
65. Leigh SR, Shea BT. 1996. Ontogeny of body size variation in African apes. Am J Phys Anthropol 99:43-66.
66. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, Stevenson JC, Coats AJS. 1997. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 18:858-865.
67. Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB. 2003. Quantification of 8-Iso-Prostaglandiin-F(2α) and 2,3-Dinor-8-Iso-Prostaglandin-F(2α) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med 34:409-418.
68. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J, Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. 2006. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577.
69. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC. 2002. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25:1919-1927.
70. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757.
71. 2, and basal and maximum aerobic capacity. Mech Ageing Dev 70:177-199.
72. Maffei P, Sicolo N, Plebani M. 1999. Lipoprotein(a) in acromegaly. Ann Intern Med 130:537-538.
73. Mak S, Newton GE. 2004. Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure. Am J Physiol Heart Circ Physiol 286:H789-H795.
74. Marson J, Meuris S, Cooper RW, Jouannet P. 1991. Puberty in the male chimpanzee: progressive maturation of semen characteristics. Biol Reprod 44:448-455.
75. Mayer M. 2000. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46:1723-1727.
76. Mead A, Atkinson G, Albin D, Alphey D, Baic S, Boyd O, Cadigan L, Clutton L, Craig L, Flanagan C, Greene P, Griffiths E, Lee NJ, Li M, McKechnie L, Ottaway J, Paterson K, Perrin L, Rigby P, Stone D, Vine R, Whitehead J, Wray L, Hooper L. 2006. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials. J Hum Nutr Diet 19:401-419.
77. Mecocci P, Polidori MC, Troiano L, Cherubini A, Cecchetti R, Pini G, Straatman M, Monti D, Stahl W, Sies H, Franceschi C, Senin U. 2000. Plasma antioxidants and longevity: a study on health centenarians. Free Radic Biol Med 28:1243-1248.
78. Mehrabi MR, Serbecic N, Ekmekcioglu C, Tamaddon F, Ullrich R, Sinzinger H, Glogar HD. 2001. The isoprostane 8epiPGF (2-alpha) is a valuable indicator of oxidative injury to human heart valves. Cardiovasc Pathol 10:241-245.
79. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. 2000. Serum uric acid and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study. Ann Epidemiol 10:136-143.
80. Munson L, Montali RJ. 1990. Pathology and diseases of great apes at the National Zoological Park Zoo. Zoo Biol 9:99-105.
81. Nakamura E, Lane MA, Roth GS, Ingram DK. 1998. A strategy for identifying biomarkers of aging: further evaluation of hematology and blood chemistry data from a calorie restriction study in rhesus monkeys. Exp Gerontol 33:421-443.
82. Nakamura K, Kushano KF, Matsubara H, Nakamura Y, Miura A, Nishii N, Banba D, Nagase S, Miyaji K, Morita H, Saito H, Emori T, Ohe T. 2005. Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail 11:117-123.
83. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. 2000. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Athersclerosis 148:131-139.
84. 2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress. Heart 89:871-874.
85. Pamplona R, Portero-Otin M, Riba D, Ruiz C, Prat J, Bellmunt MJ, Barja G. 1998. Mitochondiral membrane peroxidizability index is inversely correlated to maximum life span in mammals. J Lipid Res 39:1989-1994.
86. Perez-Campo R, López-Torres M, Cadenas S, Rojas C, Barja G. 1998. The rate of free-radical production as a determinant of aging: evidence from the comparative approach. J Comp Physiol [B] 168:149-158.
87. Roberts LJ, Morrow JD. 2000. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513.
88. Roth GS, Mattison JA, Ottinger MA, Chachich ME, Lane MA, Ingram DK. 2004. Aging in rhesus monkeys: relevance to human health interventions. Science 305:1423-1426.
89. Salomaa VV, Salminen I, Rasi V, Vahtera E, Aro A, Myllyla G. 1997. Association of fatty acid composition of serum phospholipids with hemostatic factors. Arterioscler Thromb Vasc Biol 17:809-813.
90. Sampietro T, Neglia D, Bionda A, Dal Pino B, Bigazzi F, Puntoni M, Startari U, Morales A, Minichilli F, Bianchi F, L'Abbate A. 2005. Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol 96:1718-1720.
91. Sanders TAB, Lewis F, Slaughter S, Griffin BA, Griffin M, Davies I, Millward DJ, Cooper JA, Miller GJ. 2006. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linoleic, eicosapentaenoic, and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIP study. Am J Clin Nutr 84:513-522.
92. Schulman FY, Farb A, Virmani R, Montali RJ. 1995. Fibrosing cardiomyopathy in lowland gorillas (Gorilla gorilla gorilla) in the United States: a retrospective study. J Zoo Wildl Med 26:43-51.
93. Short R, Williams DD, Bowden DM. 1997. Circulating antioxidants as determinants of the rate of biological aging in pigtailed macaques (Macaca nemestrina). J Gerontol A Biol Sci Med Sci 52:B26-B38.
94. Shukla N, Maher J, Masters J, D'Angelini G, Jeremy JY. 2006. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 187:238-250.
95. Sibley CG, Comstock JA, Alhquist JE. 1990. DNA hybridization evidence on hominoid phylogeny: a reanalysis of the data. J Mol Evol 30:202-236.
96. Smith BH, Crummett TL, Brandt KL. 1994. Ages of eruption of primate teeth: a compendium of aging individuals and comparing life histories. Yearb Phys Anthropol 37:177-231.
97. Sorg O. 2004. Oxidative stress: a theoretical model or a biological reality? C R Biol 327:649-662.
98. Stadler N, Lindner RA, Davies MJ. 2004. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24:949-954.
99. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046.
100. Takahata N, Satta Y. 1997. Evolution of the primate lineage leading to modern humans: phylogenetic and demographic inferences from DNA sequences. Proc Natl Acad Sci USA 94:4811-4815.
101. Tan KC, Shiu SW, Janus ED, Lam KS. 1997. LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-1. Atherosclerosis 129:59-65.
102. Tang YR, Zhang SQ, Xiong Y, Zhao Y, Fu H, Zhang HP, Xiong KM. 2003. Studies of five microelement contents of human serum, hair, and fingernails correlated with aged hypertension and coronary heart disease. Biol Trace Elem Res 92:97-103.
103. Tavani A, Gallus S, Negri E, Parpinel M, La Vecchia C. 2006. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic Res 40:659-664.
104. Thillet J, Doucet C, Chapman J, Herbeth B, Cohen D, Faure-Delanef L. 1998. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Atherosclerosis 136:389-394.
105. Tolmasoff JM, Ono T, Cutler RG. 1980. Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc Natl Acad Sci USA 77:2777-2781.
106. Topuzoglu G, Erbay AR, Karul AB, Yensel N. 2003. Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy. Biol Trace Elem Res 95:11-17.
107. Tulenko TN, Sumner AE. 2002. The physiology of lipoproteins. J Nucl Cardiol 9:638-649.
108. Videan EN, Fritz J, Murphy J. 2008. Effects of aging on hematology and serum chemistry in chimpanzees (Pan troglodytes). Am J Primatol 70:327-338.
109. Voss P, Siems W. 2006. Clinical oxidation parameters of aging. Free Radic Res 40:1339-1349.
110. Wannamethee SG. 2005. Serum uric acid and risk of coronary heart disease. Curr Pharm Des 11:4125-4132.
111. Waring WS, Webb DJ, Maxwell SR. 2000. Uric acid as a risk factor for cardiovascular disease. Q J Med 93:707-713.
112. Wells SK, Sargent EL, Andrews ME, Anderson D. 1990. Medical Management of the Orangutan. New Orleans: The Audubon Institute.
113. Wendland E, Farmer A, Glasziou P, Neil A. 2006. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92:166-169.
114. Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J. 2005. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2:e76.
115. Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG, Krauss RM. 2003. Smallest LDL particles are most strongly correlated with coronary disease progression in men. Arterioscler Thromb Vasc Biol 23:314-321.
116. Wolfram R, Oguogho A, Palumbo B, Sinzinger H. 2005. Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8epiPGF2?. Eur J Heart Fail 7:167-172.
117. Wright AJA, Hughes DA, Bailey AL, Southon S. 1999. Beta-carotene and lycopene, but not lutein, supplementation changes the plasma fatty acid profile of healthy male non-smokers. J Lab Clin Med 134:592-598.
118. Wu LL. 1999. Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 29:127-133.
119. Young LG, Gould KG, Smithwick EB. 1993. Selected endocrine parameters of the adult male chimpanzee. Am J Primatol 31:287-297.
120. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154-160.